Imreg, Inc.
New Orleans, LA, US· latest recorded location
Imreg, Inc. is named on 12 US grants and 0 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 12
- Published applications
- 0
- Inventors
- 4
- Granted in 2026 so far
- 0
- Most recent grant
- 31 Mar 1992
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
By publication year.
Technology areas
Share of 12 documents
- A61KMedicines and medical preparations10
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6
- G01NInvestigating or analysing materials by determining their chemical or physical properties4
- C07KPeptides3
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3
- C12NMicroorganisms or enzymes1
- Y02ATechnologies for adaptation to climate change1
Recent patents
- Tyr-Gly compositions useful in increasing immune response31 Mar 1992US 5,100,663 A
- Dialysates for treating aids and arc and for otherwise increasing immune response3 Mar 1992US 5,093,321 A
- Method of showing progression of AIDS in an ARC patient by treating with Tyr-Gly compositions14 Jan 1992US 5,081,108 A
- Methods for modulating antibody production in treating patients with AIDS, ARC and other diseases7 May 1991US 5,013,546 A
- Immunosuppressor and method of extraction thereof from leukocytes24 Apr 1990US 4,920,097 A
No published applications.
Most cited
By later US patents
- Tripeptides affecting immune response28US 4,699,898 A1987
- Methods for treating AIDS and ARC18US 4,751,216 A1988
- Diagnostic methods for immune function17US 4,778,750 A1988
- Sensitive tests for malignancies based on DNA detection13US 4,490,472 A1984
- Treatment of autoimmune disorders with immunoamplifiers13US 4,710,380 A1987